Search results

1. Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic …

Principal investigator: dr hab. Katarzyna Zofia Kuter-Nowak

Instytut Farmakologii PAN

Call: OPUS 18, Panel: NZ7

2. Normal021falsefalsefalseMicrosoftInternetExplorer4/* Style Definitions */table.MsoNormalTable{mso-style-name:Standardowy…

Principal investigator: dr Anna Gąsiorowska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA 1, Panel: NZ7

3. Spatial analysis of the effects of L-DOPA on gene expression in the prefrontal cortex in a mouse model of Parkinson's di…

Principal investigator: dr Anna Aleksandra Radlicka-Borysewska

Instytut Farmakologii PAN

Call: PRELUDIUM 19, Panel: NZ4

4. The role of aged microglia in exacerbating Parkinson's Disease pathology

Principal investigator: prof. Leonora Maria Bużańska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 28 (LAP), Panel: NZ5

5. Modeling Progression of α-Synucleinopathy in Noradrenergic and Serotonergic Systems – Possible Link with Prodromal Sympt…

Principal investigator: Anna Hajam Alwani

Instytut Farmakologii PAN

Call: PRELUDIUM 23, Panel: NZ4

6. Evaluation of P2X7 purinergic receptor as a trigger of brain metabolic abnormalities and neuronal degeneration in a mous…

Principal investigator: dr Anna Wilkaniec

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA BIS 13, Panel: NZ4

7. Biological control and pharmacological regulation of RNAs implicated in aetiology of Parkinson's disease

Principal investigator: prof. Gracjan Patryk Michlewski

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

Call: OPUS 25, Panel: NZ1

8. Dysfunction of NFE2L1 and other family members causes damage in dopaminergic neuron function through dysregulated transc…

Principal investigator: Kamila Łuczyńska

Instytut Genetyki i Hodowli Zwierząt PAN

Call: PRELUDIUM 21, Panel: NZ5

9. New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson's disease.

Principal investigator: dr hab. Małgorzata Kujawska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA BIS 11, Panel: NZ7

10. Learned irrelevance in idiopathic Parkinson's disease: searching for a neurochemical basis and implications for patients…

Principal investigator: Aleksandra Fijałkiewicz

Uniwersytet Jagielloński, Wydział Filozoficzny

Call: PRELUDIUM 20, Panel: HS6

11. The mechanisms of mitochondrial damage-dependent neuroinflammation in experimental models of Parkinson's disease. The ro…

Principal investigator: prof. Agata Adamczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 20 (LAP), Panel: NZ4

12. Regulation of microRNAs for the treatment and understanding the etiology of Parkinson's disease

Principal investigator: dr hab. Gracjan Patryk Michlewski

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

Call: Polskie Powroty NAWA 2020, Panel: NZ1

13. The importance of the crosstalk between alpha-synuclein and sphingosine-1-phosphate-dependent signalling in experimental…

Principal investigator: dr Joanna Agata Motyl

Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza PAN

Call: SONATINA 3, Panel: NZ4

14. Prolonged high intensity interval training (HIIT) modulates inflammation through the specific microRNAs level changes in…

Principal investigator: Paulina Anna Małczyńska-Sims

Instytut Psychiatrii i Neurologii

Call: PRELUDIUM 16, Panel: NZ7

15. Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context…

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii PAN

Call: OPUS 13, Panel: NZ7

16. Effect of high intensity interval training on mechanisms of neuroplasticity and psychomotor behaviours in Parkinson's di…

Principal investigator: prof. Jarosław Marusiak

AKADEMIA WYCHOWANIA FIZYCZNEGO WE WROCŁAWIU, Wydział Fizjoterapii

Call: OPUS 13, Panel: NZ7

17. Dissecting pathomechanisms of idiopathic form of Parkinson's Disease using induced pluripotent stem cells technology

Principal investigator: prof. Marcin Marek Majka

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 9, Panel: NZ5

18. Modulation of mitochondrial calcium traffic in pink1 mutant Zebrafish model of Parkinson's disease

Principal investigator: dr Smijin Karthully Soman

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

Call: SONATA 8, Panel: NZ3

19. The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t…

Principal investigator: Joanna Agata Motyl

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 5, Panel: NZ4

20. The involvement of P2 purinergic receptors in alpha-synuclein mediated mitochondrial dysfunction. Relevance to Parkinson…

Principal investigator: dr Anna Wilkaniec

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA 5, Panel: NZ3

21. The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m…

Principal investigator: dr Agnieszka Wąsik

Instytut Farmakologii PAN

Call: OPUS 4, Panel: NZ7

22. The role of astrocytes and cellular metabolism in functional compensation of degeneration of dopaminergic system in the …

Principal investigator: dr Katarzyna Kuter

Instytut Farmakologii PAN

Call: OPUS 3, Panel: NZ4

23. Algorithmic estimation of eye movements changes in relation to development of Parkinson's disease

Principal investigator: dr hab. Andrzej Przybyszewski

Polsko-Japońska Akademia Technik Komputerowych

Call: OPUS 2, Panel: ST6

24. Effect of various types of acute exercise and exercise trening on NO/sGC/cGMP pathway and death of dopaminergic neurons …

Principal investigator: prof. Małgorzata Chalimoniuk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 1, Panel: NZ5

25. Influence of music therapy to improve quality of gait and selected daily live activities in a group of patients with Par…

Principal investigator: Anna Aldona Bukowska

AKADEMIA WYCHOWANIA FIZYCZNEGO IM. BRONISŁAWA CZECHA W KRAKOWIE, Wydział Rehabilitacji Ruchowej

Call: PRELUDIUM 3, Panel: NZ7

26. Effect of Urolithin A on gut microbiota and intestinal integrity contributing to neuroprotective effects in a model of P…

Principal investigator: Olga Wojciechowska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 23, Panel: NZ7

27. Interaction between temporal predictability and action control in ADHD and Parkinson's Disease: behavioural, neurophysio…

Principal investigator: dr Inga Justyna Korolczuk

Uniwersytet Medyczny w Lublinie

Call: SONATINA 8, Panel: HS6

28. The link between circadian clock, light pollution and Parkinson's disease development - research on Drosophila melanogas…

Principal investigator: dr hab. Milena Anna Damulewicz

Uniwersytet Jagielloński, Wydział Biologii

Call: SONATA BIS 12, Panel: NZ3

29. Frontal lobes characteristic symptoms in Parkinson's disease.

Principal investigator: Paulina Beata Golińska

Uniwersytet Gdański, Wydział Nauk Społecznych

Call: PRELUDIUM 17, Panel: HS6

30. The role of circadian clock, Nrf2 transcription factor and haeme oxygenase in the regulation of innate immune responses.…

Principal investigator: prof. Elżbieta Małgorzata Pyza

Uniwersytet Jagielloński, Wydział Biologii

Call: OPUS 15, Panel: NZ3

31. Urolithin A as a metabolite of ellagitannins with potential neuroprotective activity - the research of mechanisms of thi…

Principal investigator: dr Małgorzata Kujawska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 13, Panel: NZ7

32. The role of Parkin in exogenous Alpha-synuclein-induced cell death. Implications for pathogenesis of Parkinson's disease…

Principal investigator: dr hab. Agata Adamczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: OPUS 3, Panel: NZ3

33. Contribution of nitrergic transmission in the modulation of L-dopa activity in the rat 6-OHDA model of Parkinson's disea…

Principal investigator: dr hab. Elżbieta Kazimiera Lorenc-Koci

Instytut Farmakologii PAN

Call: OPUS 1, Panel: NZ4

34. New aryl difluoromethylenephosphonic acid and thiazole conjugates as effective PTP1B inhibitors used in the treatment of…

Principal investigator: Dominika Agnieszka Kołodziej-Sobczak

Uniwersytet Mikołaja Kopernika

Call: PRELUDIUM 24, Panel: ST5

35. Effect of drugs, mitochondrial proteins and miRNA biomarkers of neurodegenerative diseases on dynamics and conversion of…

Principal investigator: dr hab. Sławomir Roman Jakieła

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

Call: SONATA BIS 9, Panel: ST4

36. New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc…

Principal investigator: Michał Karol Załuski

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: PRELUDIUM 12, Panel: NZ7

37. Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng…

Principal investigator: Justyna Beata Barut

Instytut Farmakologii PAN

Call: PRELUDIUM 18, Panel: NZ7

38. How inactivation of Mitochondrial Calcium Uniporter protects dopaminergic neurons

Principal investigator: prof. Jacek Marceli Kuźnicki

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

Call: OPUS 25, Panel: NZ4

39. Small-molecule inhibitors of protein aggregation and ER stress as a novel strategy against neurodegeneration in the cour…

Principal investigator: prof. Ireneusz Jacek Majsterek

Uniwersytet Medyczny w Łodzi

Call: PRELUDIUM BIS 3, Panel: NZ5

40. Analysis of the molecular mechanism of phosphorylated α-synuclein and ubiquitinated protein accumulation caused by dopam…

Principal investigator: dr Hiroaki Taniguchi

Instytut Genetyki i Hodowli Zwierząt PAN

Call: PRELUDIUM BIS 2, Panel: NZ5

41. In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological …

Principal investigator: dr Piotr Chmielarz

Instytut Farmakologii PAN

Call: SONATA 15, Panel: NZ7

42. Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege…

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ7

43. Assessment of the state and function of the brain cholinergic system in animal models of Alzheimer-type and frontotempor…

Principal investigator: dr hab. Grażyna Niewiadomska

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 8, Panel: NZ4

Projects search